Smoking cessation works best when you pair a plan with the right tool, not willpower alone. This page reviews smoking cessation products, both prescription and over the counter, that Canadian clinicians and pharmacists actually recommend. You also need to be aware of the effects of smoking cessation in the first weeks and years. No single product fits every smoker. However, smoking cessation options such as nicotine replacement therapy, varenicline, bupropion, and cytisine each work best in specific situations, have a short list of people who should avoid them, and come with side‑effect profiles you should understand before starting.

Guidelines in Canada tell us to offer every adult who smokes at least one proven option. Healthcare providers usually consider factors like dependence, medical history, cost, lifestyle, and what you will actually use. Studies show that using more than one quit‑smoking treatment works better than using only a nicotine patch. In addition, counseling combined with medicine beats medicine alone. Therefore the best smoking cessation products are the ones you can take as prescribed for 8–12 weeks, not the brand with the loudest ad.
Varenicline often leads the evidence‑based options for efficacy, with combination nicotine‑replacement therapy close behind. Cytisine now appears in Canadian recommendations as a natural alternative with supportive data. Bupropion on the other hand offers additional benefits when mood or appetite also need attention. Nevertheless, single‑form NRT still plays an important role for lighter smokers and for people who cannot take tablet‑based medications. Doctors assess your medical history, lifestyle, allergies and personal preference to tailor the best plan.

These smoking cessation products give clean nicotine to keep cigarettes away.
Nicotine Replacement Patch: One nicotine replacement patch can help you for the entire day. It is a transdermal adhesive sticker that delivers a slow, steady amount of nicotine through the skin into the bloodstream to help people quit smoking or vaping. It eases withdrawal symptoms and reduce cravings without the toxic chemicals in tobacco smoke. Many of us start with a 21 mg patch if you smoke more than 10 cigarettes a day, or 14 mg if you smoke fewer, then add a short-acting piece when a craving hits. After 4–6 weeks we step the patch down.
Gum, lozenge, inhaler, or sprays: They are short-acting medical products designed to help people quit smoking by delivering small, controlled doses of nicotine to ease cravings and withdrawal symptoms. They enter the bloodstream quickly through the lining of the mouth or nose, reducing sudden cravings in 2 to 5 minutes. You can use them when you have a sudden craving while of a long-acting option such as a patch.
Nicotine‑replacement therapy (NRT) reduces physical withdrawal by safely easing intense symptoms such as irritability, anxiety, trouble concentrating, and mood swings, allowing you to focus on the behavioural and emotional parts of quitting. NRT also eliminates combustible toxins, because nicotine itself does not cause cancer or lung disease; it removes exposure to tars, carbon monoxide, and thousands of other harmful chemicals found in smoke. In addition, NRT has low addictive potential because it absorbs slowly compared with cigarettes, making it much easier to taper off over time. Additionally, you can buy most forms without a prescription; combination NRT is one of the strongest over-the-counter plans.
You may benefit from NRT in several situations, especially when nicotine dependence shows up consistently:
People should avoid or modify nicotine‑replacement therapy in specific situations. Skip the patch on broken, eczematous, or psoriatic skin, and avoid gum if dentures make chewing unsafe. After using gum or lozenges, wait 15 minutes before consuming acidic drinks because they reduce absorption. Pregnant or breastfeeding individuals should consult a clinician first, as short‑acting NRT is usually preferred over tablets. Teens also need a prescriber rather than experimenting with drugstore products.
Varenicline actively helps adults quit smoking by reducing withdrawal symptoms and lowering the urge to smoke. It binds directly to nicotine receptors in the brain, blocks nicotine from creating pleasurable sensations when someone smokes, and partially stimulates those receptors just enough to ease cravings. Its active ingredient, varenicline tartrate, targets the same receptors involved in nicotine addiction to support the quitting process. You start 0.5 mg daily for three days, then twice daily, then 1 mg twice daily if you tolerate it, and you pick a quit date in the first two weeks—or a flexible quit window.
Varenicline reduces withdrawal symptoms, cuts the urge to smoke, and blocks nicotine from creating pleasurable effects, which makes cigarettes less rewarding. It also lowers cravings by partially stimulating nicotine receptors just enough to ease discomfort without delivering nicotine itself. By acting on the same receptors that drive dependence, Varenicline helps people stay smoke‑free, improves quit rates, and supports long‑term abstinence more effectively than most single‑form smoking cessation products.
The most common side effects of varenicline come from how it interacts with nicotine receptors in the brain.
Most of these effects fade as the dose stabilizes, and clinicians often adjust timing or titration to reduce them.
Adults with moderate or high dependence who prefer taking tablets and can continue it for 12-week course can use it.
Varenicline helps adults who smoke daily, supports people with strong cravings, and benefits those who experience intense withdrawal symptoms when they try to quit. It also works well for smokers who want a non‑nicotine option, because it targets the same receptors without delivering nicotine. Clinicians often recommend it for people who prefer a structured, prescription‑based quit plan, and for those who need higher quit success rates than single‑form NRT typically provides.
People with a history of severe allergic reactions to varenicline should avoid it entirely. Clinicians also use caution or choose alternatives for people who currently experience unstable mood symptoms, untreated depression, or recent suicidal thoughts, because withdrawal and receptor‑targeting medications can complicate mental‑health stability. Individuals with significant kidney impairment often need dose adjustments, and some may need to avoid the medication depending on their kidney function. Pregnant or breastfeeding individuals typically avoid varenicline because safety data remain limited. Finally, people who cannot tolerate the early side effects—especially persistent nausea or sleep disruption—may need a different cessation option.
Bupropion SR are sustained‑release prescription-based smoking cessation products that help people quit smoking. They act on the brain chemicals involved in mood, reward, and nicotine dependence. It reduces nicotine cravings, eases withdrawal symptoms, and helps stabilize mood during the quitting process. It works by increasing norepinephrine and dopamine activity, which makes the brain less dependent on nicotine for reward and stress relief. Because it does not contain nicotine, it offers a non‑nicotine option for people who prefer a tablet‑based quit plan or who also need support for low mood or increased appetite while quitting.
Dose is often 150 mg daily for three days, then 150 mg twice daily. You set a quit date in the second week.
Bupropion reduces nicotine cravings, eases withdrawal symptoms, and helps stabilize mood during the quitting process. It also lowers the risk of post‑quit weight gain by influencing appetite‑related pathways. Because it boosts norepinephrine and dopamine activity, it makes the brain less dependent on nicotine for reward, which strengthens quit attempts. Many clinicians also use Bupropion SR for people who struggle with low mood, giving it a dual benefit when depression and smoking coexist.
Bupropion SR isn’t suitable for everyone, and certain groups should avoid it or use it only with careful clinical supervision.
Cytisine is a plant‑derived smoking‑cessation medicine that works on the same (α4β2) nicotine receptors involved in nicotine addiction, similar to varenicline. However it has a gentler, shorter‑acting effect. It binds to nicotine receptors, reduces cravings, and blocks nicotine from creating pleasurable effects, which makes smoking less rewarding. It also eases withdrawal symptoms by partially stimulating those receptors without delivering nicotine itself. In Canada, cytisine was recently added to the recommended smoking‑cessation options as a Natural Health Product (NHP). Clinical guidelines now include cytisine alongside varenicline, bupropion, and nicotine‑replacement therapy, especially for people who prefer smoking cessation products that are natural, plant-based, non‑prescription, as well as receptor‑targeting.
Packs use a tapering tablet schedule over about 25 days.
Cytisine reduces cravings, eases withdrawal symptoms, and blocks nicotine from creating pleasurable effects, which makes smoking less rewarding. It also helps people maintain abstinence by partially stimulating the receptors just enough to reduce discomfort without delivering nicotine. Evidence shows Cytisine offers a higher quit rate than placebo. Lastly, it is one of the best options for people who prefer a short, structured course.
The side effects of Cytisine are not too different from Varenicline.
Nevertheless, most of these effects fade as the dose tapers, since these natural smoking cessation products follow a short, structured treatment schedule.
Doctors generally avoid or de-prioritize certain smoking cessation products when evidence shows they are less effective, less safe, or less reliable than the recommended firstline options (NRT, varenicline, bupropion SR, and cytisine).
Unregulated herbal remedies — Doctors avoid smoking cessation products like lobelia, “herbal cigarettes,” or detox teas because they lack evidence and may contain harmful substances.
E‑cigarettes for smoking cessation — Clinicians do not prefer vaping as a quit method due to inconsistent evidence, nicotine dependence risks, and lung‑injury concerns.
Hypnotherapy products — Hypnosis apps, recordings, or devices have weak evidence and unpredictable results.
Acupuncture devices — Again, Ear‑acupuncture kits and pressure‑point gadgets lack strong clinical support for smoking cessation.
Unapproved nicotine‑free pills — Many “quit‑smoking supplements” sold online are unregulated. The side effects of smoking cessation products like these include interaction with ongoing medications.
Laser therapy for quitting — Laser‑based cessation treatments have no reliable evidence and are not recommended in guidelines.
Single‑form NRT for heavy smokers — Doctors don’t prefer only gum or only patches for heavy smokers because combination NRT works better.

Different smoking cessation products have different side effects. However, the positive effects of smoking cessation on your health start fast. Firstly, your heart rate and carbon monoxide fall within a day. Then taste and smell return to normal. Within a year, coronary risk drops sharply. Eventually, stroke and cancer risk reduces.
Short-term side effects of smoking cessation may include cough as cilia wake up, hunger, constipation, dry mouth, sleep disturbances, and a raw mood. That is expected. Yet, they are not reasons strong enough to stop using them. This is because the long term effects on smoking on blood pressure, lungs, heart, and life span are far more harmful than those first weeks.
In conclusion, smoking cessation is a medical treatment. The preferred smoking cessation products in Canada are combination NRT, varenicline, cytisine, and bupropion, chosen against your body and your history. The effects of smoking cessation include early withdrawal and large long-term gains. Pick one evidence-based product, add counseling, and stay on it long enough for the brain to reset. You can get more information from You Drug Mart.
In Winnipeg our pharmacy, You Drug Mart offers smoking cessation program. Also you can ask a participating pharmacy about the Manitoba pharmacist quit service. You can also try the Tobacco Quit Card and counseling Program if you qualify. Additionally, ManitobaQuits is a free peer support and quitting program run by the Manitoba Lung Association to help people stop smoking or vaping. You can reach them at 1-877-513-5333.
It is counseling, texts, groups, or follow-up that sits beside medicine. Support handles triggers. Medicine handles receptor craving.
They are the patches, gum, lozenges, inhalers, sprays, varenicline, bupropion, and cytisine described above. They are not herbal cigarettes.
Smoking‑cessation therapy is a structured treatment approach that helps people quit smoking by combining nicotine‑replacement options, prescription medications, and behavioural counseling to reduce withdrawal, manage cravings, and build long‑term habits that support staying smoke‑free.
Set a date, start a recommended product before or on that date, remove cigarettes from the house, and book follow-up. Repeat after slips. Most people need more than one serious try. Take professional help for more effective results.
You can deal with cigarette addiction by combining nicotine‑replacement therapy, prescription medications, and behavioural counseling to control cravings and withdrawal. Build a clear quit plan, remove triggers, and use short‑acting NRT during sudden urges. Stay consistent with followups and adjust your supports as needed to maintain long‑term success.
Quitting smoking can cause temporary low mood or mild depression because your brain adjusts to lower dopamine and lack of nicotine‑driven rewards. People may experience an irritable mood, and sadness, during the first one to two weeks, but these symptoms usually improve as the brain resets. You can reduce this dip by using nicotine‑replacement therapy, staying active, and getting behavioural support during the transition. People with prior depression need a closer watch. Bupropion may help some. New or worsening depression needs a same-week call, not a silent wait.
Use the same smoking cessation products at doses the kidneys and skin can handle. Start with nicotine‑replacement therapy or cessation medications to reduce withdrawal, and offer them simple counseling support that focuses on routines, triggers, and confidence‑building.
Many people need several attempts. Each treated attempt still raises the odds. However, it is not impossible.
Irritability, restlessness, poor sleep, hunger, trouble concentrating, low mood, and a strong urge to smoke, peaking in the first week and easing over two to four weeks. Medicine shortens that list.
